The approval of QUVIVIQ™, a novel dual orexin receptor antagonist, is based on robust clinical efficacy and safety data, including from a Phase 3 trial in Japan that met all primary and secondary ...
New York, Sept. 24 (Jiji Press)--Japan's government promoted Japanese tourism and food at an event in New York Monday. Products including sake and traditional "Wajima-nuri" lacquerware produced in ...